Hemispherx Biopharma Board Appoints New President
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- AXT-Tongmei signs 3-year wafer supply deal with Coherent
Hemispherx Biopharma (HEB) Reports Q2 Loss of $0.04/Share
August 13, 2015 9:02 AM EDTHemispherx Biopharma (NYSE: HEB) reported Q2 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on Hemispherx Biopharma (HEB) click here.
... More